Brian Slater and Greg Sephton Join Sterlington to bolster IP and Life Sciences practice areas
Sterlington is proud to announce the strategic addition of two senior partners to its team as Co-Heads of Sterlington’s Intellectual Property (IP) practice.
New York, September 29, 2023 – Sterlington is proud to announce the strategic addition of two senior partners to its team as Co-Heads of Sterlington’s Intellectual Property (IP) practice. With their extensive experience in IP and life sciences, the appointments of Brian Slater and Greg Sephton mark another significant step in the firm’s commitment to providing top-tier legal counsel to clients.
Brian Slater is a lead trial lawyer who has represented industry giants including Gilead, Merck, Novartis, Regeneron, and Sanofi, in high-stakes intellectual property disputes. Greg Sephton has also represented pharmaceutical and biotechnology innovators, including AstraZeneca, Novartis, Merck, and Regeneron, in high-stakes patent litigation. They both have extensive experience in high value Hatch-Waxman patent litigations representing branded pharmaceutical companies against generic drug challengers, as well as bet-the-company patent cases involving biologics and lipid nanoparticle technology. They also counsel emerging and established life sciences companies on protecting, licensing, and monetizing their IP assets.
Among his prior firms, Brian was a partner at Kramer Levin Naftalis & Frankel LLP, where he was Chair of Life Sciences. Before that, he spent over 20 years at the IP boutique, Fitzpatrick, Cella, Harper & Scinto (now Venable LLP), where he served on the management committee. Brian has been recognized by Intellectual Asset Management Patent 1000: The World’s Leading Patent Professionals, and as a Life Sciences Lawyer by LMG Life Sciences. He obtained his LL.M. from the University of Pennsylvania, where he was a Thouron Scholar.
Among his prior firms, Greg was a partner at Kramer Levin Naftalis & Frankel LLP and before that, was a partner at Fitzpatrick, Cella, Harper & Scinto (now Venable LLP), where he practiced for more than 20 years. He obtained his J.D. from Suffolk University, his Ph.D. in biochemistry from Brandeis University and his B.Sc. (Hons) in chemistry and biochemistry from the University of Toronto.
Commenting on the appointments, Chris Harrison, founding partner of Sterlington said “We are delighted to welcome Brian and Greg to our team here at Sterlington. Their significant expertise in IP litigation and strong relationships within the life sciences industry will enhance our capabilities and our position as a trusted legal partner in this area.”
Read full bios:
About Sterlington PLLC
Sterlington PLLC is an international virtual law firm with leading capabilities in sophisticated litigation and transactional work, and legal operations outsourcing. With deep experience and specialized skills across multiple practices and industries, our team helps clients around the world achieve their business goals.
What will the law firm of the future look like?
Time travellers from 100 years ago would find the modern law firm a curious beast: On the one hand, litigators spend their days preparing pleadings and giving oral argument in court; transactional lawyers spend their days preparing and reviewing contracts, deeds and agreements. Lawyers in 2023 do pretty much the same thing. On the other hand, the way in which that work is carried out is radically different. Law firms are increasingly diverse, and no longer the sole province of the most privileged in society. And instead of doing everything by hand, or dictating to clerical staff, lawyers are expected to be adept with a range of different tech tools.
Sterlington Welcomes Todd McClelland as Partner in Data Privacy, AI and Litigation practices
Sterlington, an international law firm, is pleased to announce the appointment of Todd McClelland as a Partner in Sterlington’s Cybersecurity, Data Privacy, AI and Litigation practices. As a recognized leader in cybersecurity and data privacy, Todd’s expertise will strengthen Sterlington’s capabilities in these strategic areas of focus for the firm.
What Is an NDA? Everything About Outsourcing NDAs
Interested in learning more about non-disclosure agreements? Explore our comprehensive guide to NDAs and why outsourcing your NDAs is the ideal option